106 related articles for article (PubMed ID: 10609788)
1. Expression of interferon regulatory factor 1 and 2 in hematopoietic cells of children with juvenile myelomonocytic leukemia.
Mild GC; Schmahl GE; Shayan P; Niemeyer CM
Leuk Lymphoma; 1999 Nov; 35(5-6):507-11. PubMed ID: 10609788
[TBL] [Abstract][Full Text] [Related]
2. Quantitation of interferon regulatory factor transcripts in patients with acute myeloid leukemia.
Perambakam S; Li B; Preisler H
Cancer Invest; 2001; 19(4):346-51. PubMed ID: 11405174
[TBL] [Abstract][Full Text] [Related]
3. Expression of the Evi-1 gene in haemopoietic cells of children with juvenile myelomonocytic leukaemia and normal donors.
Gerhardt TM; Schmahl GE; Flotho C; Rath AV; Niemeyer CM
Br J Haematol; 1997 Dec; 99(4):882-7. PubMed ID: 9432037
[TBL] [Abstract][Full Text] [Related]
4. Gene expression of the hematopoietic cell phosphatase in juvenile myelomonocytic leukemia.
Wütz D; Shayan P; Schmahl GE; Mild GC; Feil B; Röll S; Kontny HU; Niemeyer CM
Leuk Lymphoma; 1999 Nov; 35(5-6):491-9. PubMed ID: 10609786
[TBL] [Abstract][Full Text] [Related]
5. Identification of the lysyl oxidase gene as target of the antioncogenic transcription factor, IRF-1, and its possible role in tumor suppression.
Tan RS; Taniguchi T; Harada H
Cancer Res; 1996 May; 56(10):2417-21. PubMed ID: 8625321
[TBL] [Abstract][Full Text] [Related]
6. Quantitation of multiple myeloma oncogene 1/interferon-regulatory factor 4 gene expression in malignant B-cell proliferations and normal leukocytes.
Yamada M; Asanuma K; Kobayashi D; Moriai R; Yajima T; Yagihashi A; Yamamori S; Watanabe N
Anticancer Res; 2001; 21(1B):633-8. PubMed ID: 11299818
[TBL] [Abstract][Full Text] [Related]
7. Id2 expression increases with differentiation of human myeloid cells.
Ishiguro A; Spirin KS; Shiohara M; Tobler A; Gombart AF; Israel MA; Norton JD; Koeffler HP
Blood; 1996 Jun; 87(12):5225-31. PubMed ID: 8652837
[TBL] [Abstract][Full Text] [Related]
8. Expression of tumor-suppressor genes interferon regulatory factor 1 and death-associated protein kinase in primitive acute myelogenous leukemia cells.
Guzman ML; Upchurch D; Grimes B; Howard DS; Rizzieri DA; Luger SM; Phillips GL; Jordan CT
Blood; 2001 Apr; 97(7):2177-9. PubMed ID: 11264190
[TBL] [Abstract][Full Text] [Related]
9. Interferon-gamma regulation of the human mimecan promoter.
Tasheva ES; Conrad GW
Mol Vis; 2003 Jun; 9():277-87. PubMed ID: 12835654
[TBL] [Abstract][Full Text] [Related]
10. Interferon regulatory factor-1 gene abnormality and loss of growth inhibitory effect of interferon-alpha in human hepatoma cell lines.
Tada S; Saito H; Tsunematsu S; Ebinuma H; Wakabayashi K; Masuda T; Ishii H
Int J Oncol; 1998 Dec; 13(6):1207-16. PubMed ID: 9824633
[TBL] [Abstract][Full Text] [Related]
11. Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development.
Matsuyama T; Kimura T; Kitagawa M; Pfeffer K; Kawakami T; Watanabe N; Kündig TM; Amakawa R; Kishihara K; Wakeham A
Cell; 1993 Oct; 75(1):83-97. PubMed ID: 8402903
[TBL] [Abstract][Full Text] [Related]
12. Regulation of interferon responses in medulloblastoma cells by interferon regulatory factor-1 and -2.
Park KC; Shimizu K; Hayakawa T; Tanaka N
Br J Cancer; 1998 Jun; 77(12):2081-7. PubMed ID: 9649118
[TBL] [Abstract][Full Text] [Related]
13. Structure and regulation of the human interferon regulatory factor 1 (IRF-1) and IRF-2 genes: implications for a gene network in the interferon system.
Harada H; Takahashi E; Itoh S; Harada K; Hori TA; Taniguchi T
Mol Cell Biol; 1994 Feb; 14(2):1500-9. PubMed ID: 7507207
[TBL] [Abstract][Full Text] [Related]
14. Interferon regulatory factors: growth control and histone gene regulation--it's not just interferon anymore.
Vaughan PS; van Wijnen AJ; Stein JL; Stein GS
J Mol Med (Berl); 1997 May; 75(5):348-59. PubMed ID: 9181476
[TBL] [Abstract][Full Text] [Related]
15. Transcription factor IRF-2 exerts its oncogenic phenotype through the DNA binding/transcription repression domain.
Nguyen H; Mustafa A; Hiscott J; Lin R
Oncogene; 1995 Aug; 11(3):537-44. PubMed ID: 7630638
[TBL] [Abstract][Full Text] [Related]
16. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation.
Liebermann DA; Hoffman B
Stem Cells; 1994 Jul; 12(4):352-69. PubMed ID: 7951003
[TBL] [Abstract][Full Text] [Related]
17. [Study on expression of IRF-1 gene in human leukemia with RT-PCR and the silver sequence techniques].
Xia F; Yuan Y; Zhang W
Zhonghua Xue Ye Xue Za Zhi; 1998 Jan; 19(1):13-5. PubMed ID: 10921095
[TBL] [Abstract][Full Text] [Related]
18. EVI-1 gene expression in myeloid clonogenic cells from juvenile myelomonocytic leukemia (JMML).
Privitera E; Longoni D; Brambillasca F; Biondi A
Leukemia; 1997 Dec; 11(12):2045-8. PubMed ID: 9447818
[TBL] [Abstract][Full Text] [Related]
19. Lack of IRF-1 expression in acute promyelocytic leukemia and in a subset of acute myeloid leukemias with del(5)(q31).
Green WB; Slovak ML; Chen IM; Pallavicini M; Hecht JL; Willman CL
Leukemia; 1999 Dec; 13(12):1960-71. PubMed ID: 10602416
[TBL] [Abstract][Full Text] [Related]
20. Expression of interferon regulatory factor 4 in chronic myeloid leukemia: correlation with response to interferon alfa therapy.
Schmidt M; Hochhaus A; König-Merediz SA; Brendel C; Proba J; Hoppe GJ; Wittig B; Ehninger G; Hehlmann R; Neubauer A
J Clin Oncol; 2000 Oct; 18(19):3331-8. PubMed ID: 11013272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
